We would appreciate your feedback to help with continued improvement of this resource.
Dr Ghee Chew
Dr Timothy Cain
Date last modified: November 28, 2015
There are no prerequisites for this study.
This study may not be suitable for pregnant women. The benefit versus risk should be discussed with the nuclear medicine specialist.
Women who are breastfeeding and people who are the primary or sole carer for small children may need to make special preparations after the test to stop breastfeeding for a short time and to avoid close contact with young children due to the small amount of radioactivity released for a while after the test. Patients should discuss this with their referring doctor or the nuclear medicine practice where they will have the test for details. See nuclear medicine for further information about the precautions to take with nuclear medicine studies for breastfeeding patients and those in close contact with children.
Known allergy to any of the pharmacological stress agents is an obvious contraindication.
More specific contraindications for dipyridamole and adenosine:
Caution is exercised when using dobutamine in patients with suspected tendency to ventricular tachyarrythmias and in patients with atrial tachyarrythmias (particularly if not on anticoagulation).
There are no relative contraindications for the NM Cardiac Stress Test. Even in claustrophobic and obese patients, whose weight exceeds the limits of the imaging bed, can be scanned with patient sitting up and 2 dimensional (planar instead of tomographic) images acquired.
The contraindications of the pharmacological stress agents are outlined above.
The likelihood of an adverse reaction to the radiopharmaceutical is very remote, in the order of 1 in 10,000. The likelihood of a serious allergic event is even less likely. The adverse effects of the pharmacological stress agents are outlined above.
Relevant to clinical practice, the NM cardiac stress test: